11/26/2021Novo Nordisk Announces Impact from Volume Based Procurement for Insuli...

11/26/2021Simcere Announces CN Conditional Approval of Enweida (Envafolimab) C...

11/26/2021Recent Executive Movements

11/25/2021Chugai Files China's First Case of Patent Linkage at Beijing IP Court

11/25/2021China Issues IPR Protection, Application Plan in 2021-2025 Period

11/24/2021HUTCHMED and AZ Initiate SACHI P3 Trial of ORPATHYS and TAGRISSO Com...

11/24/2021NMPA Announces Package Insert Revision of Disodium Clodronate Formulat...

11/24/2021TenNor Reports Positive Results of TNP-2092 Capsule for Liver Cirrhosi...

11/24/2021Pfizer Sues Employee for Allegedly Stealing Covid-19 Vaccine Secrets

11/24/2021BeiGene Completes Acquisition of Former BMS Campus in NJ

11/24/2021BeiGene Wins EU Approval of BRUKINSA for Waldenström's Macroglobuline...

11/24/2021API Manufacturers Targeted by China's New Anti-monopoly Bureau: Pharma...

11/23/2021Patent Invalidation Strategies in Patent Infringement Disputes

11/23/2021China Emphasizes Clinical Value While the U.S. Reviews Cell Therapy wi...

11/23/2021PharmaDJ's China Licensing Deals Tracker: October 2021

11/23/2021NHC Issues Notice on Promotion of Sanming City's Healthcare Reform Exp...

11/23/2021Ji Xing Granted Chinese IND Approval for Phase 1 & 3 Trials of Etripam...

11/23/2021Lonza and Bluejay Therapeutics Ink Manufacturing Deal

11/23/2021Zenas BioPharma Acquires Exclusive Worldwide Rights to Obexelimab from...

11/22/2021CStone and Hengrui Enter Licensing Pact on Anti-CTLA-4 mAb CS1002 in ...

11/22/2021Independent Directors of Kangmei Pharma Fined Heavily, Triggering A Qu...

11/22/2021Sanofi and Baidu Enter License Agreement for Next-Generation mRNA Th...

11/22/2021China Sees Bounce in CPhI Rankings Ahead of Hybrid CPhI & P-MEC China

11/22/2021Harvard and Zhejiang University Form Collaborative Program in Clinica...

11/22/2021CNIPA Draft Provisions on IP Credit Administration (Nov 2021)

11/19/2021Why CNIPA Could Be the Go-To Venue for Chinese Patent Linkage Plaintif...

11/19/2021CDE Publicizes the List of Reference Formulations for GQCE Studies (52...

11/19/2021CDE Issues the Technical Guidelines for Minimal Residual Disease Detec...

11/19/2021CDE Issues the Technical Guidance for Clinical Trials of Generic Drug ...

11/19/2021GSK Secures Chinese Approval of Nucala (mepolizumab) for EPGA

Page:104/719 Total number of articles:21546: [First][<<] [102] [103] [104] [105] [106] [>>] [End]